You're a combat veteran considering participation.
Take the five-minute eligibility screening. If you qualify, you'll hear back from Patrick directly.
Begin the screening →The Microdosing Vets study is a doctoral research project at the California Institute of Integral Studies (CIIS) examining the qualitative experience of microdosed LSD among U.S. combat veterans living with post-traumatic stress disorder (PTSD). The study is ethics-approved, applies reflexive thematic analysis and methodological triangulation, and is the first qualitative research to treat self-directed veteran microdosing as primary data.
The current wave of psychedelic clinical research has focused on therapist-assisted high-dose protocols: MDMA for PTSD, psilocybin for treatment-resistant depression, ibogaine for traumatic brain injury. These studies are important. They are also expensive, geographically limited, and time-bounded — a single MDMA-PTSD course runs months of structured therapy in approved clinical settings.
Meanwhile, combat veterans across the country are microdosing on their own. What they are learning about dose, timing, daily-life integration, interactions with sleep, hypervigilance, intimacy, and substance co-use does not appear in the published literature.
The Microdosing Vets study treats those experiences as primary data — not as anecdote to be validated against later clinical trials, but as the substantive empirical material a qualitative dissertation can be built on.
The Microdosing Vets study examines the qualitative experience of microdosed LSD among U.S. combat veterans living with PTSD. The unit of analysis is lived experience — what veterans report about effects, integration, and meaning — captured through first-person accounts and triangulated against the observations of someone who knows the participant well.
The study is not measuring symptom reduction on a clinical scale, blood biomarkers, or dose-response curves. It is documenting what veterans are noticing, in their own words, about what microdosing does in their lives.
The study uses two methodological commitments together: reflexive thematic analysis and methodological triangulation. Both are established approaches in qualitative research; together they form the design described in A Soldier's Journey Home.
A combat veteran who has microdosed LSD for PTSD-related symptoms — and who consents to participate — sits for a remote, recorded, one-on-one interview of approximately eighty minutes. The interviewer is the principal investigator: a fellow combat veteran. The conversation is semi-structured, opening with the veteran's experience of military service and trauma, moving through their decision to begin microdosing, and following whatever the participant identifies as the meaningful effects of the practice on daily life. Questions are designed to surface lived experience, not to confirm hypotheses.
Each participant nominates someone close to them — a partner, family member, close friend, or peer — to sit for a separate interview about the participant's experience as observed from the outside. The Friendly Observer interview is conducted independently. Its purpose is methodological triangulation: pairing the participant's first-person report with the perspective of a person whose proximity gives them standing to corroborate, contradict, or contextualize what the participant has shared.
Both interview streams are transcribed, de-identified, and analyzed using reflexive thematic analysis (Braun & Clarke, 2019) — a qualitative method that surfaces patterns of meaning across cases while acknowledging the researcher's own position within the data. Reflexivity matters here: the principal investigator's experience as a combat veteran is treated as part of the interpretive frame, not as a bias to be eliminated. The full methodology is documented in the dissertation's third chapter.
A peer-reviewable account of what microdosing looks like, sounds like, and means for U.S. combat veterans with PTSD — built from cases rather than population averages, and capable of generating the questions that future clinical trials will need to ask.
The Microdosing Vets study is approved by the CIIS Ethics Board and conducted under the standards of that approval. Participation involves several layers of protection designed for a population whose disclosure carries real risk.
The five-minute eligibility screening does not require legal name, address, or service-record verification. Participants can complete it under a pseudonym and back out at any point with no record retained.
All interview content is transcribed, stored, and analyzed with personal identifiers removed. Direct quotes used in the dissertation and any subsequent publications are presented without information that would re-identify the participant to outside readers.
The research does not provide treatment recommendations, prescribe microdosing protocols, supply substances, or refer participants to suppliers. Veterans who screen out are not flagged, contacted, or tracked. The role of the researcher is to listen and document — not to direct or advise.
Participation is voluntary at every stage. Participants can pause, decline a question, or withdraw from the study entirely at any point — including after the interview — and have their data removed from analysis.
Patrick enlisted in the Ohio Army National Guard during his freshman year of college, after September 11, 2001. A 19-month deployment in support of Operation Iraqi Freedom followed. He returned home and built a career in holistic health, founding a wellness community in the Greater Cincinnati area and earning dual master's degrees in complementary and alternative medicine and herbal medicine.
Years of that work clarified what had not been reachable through gym, yoga, nutrition, or community alone. The conventional treatment pathways available to him as a veteran had not reached the root of what war had left in him, in his family, and in the broader military community.
Encountering psychedelics opened a different therapeutic register — not as recreational substances or miracle cures, but as carefully bounded tools whose effects on lived experience deserved serious documentation. Around the same period, he began formal training in Vipassana meditation, a Buddha-lineage contemplative practice with an established place within transpersonal psychology, and it continues to inform his approach. The doctoral research now underway at CIIS is the formalization of the psychedelic inquiry, focused on the population whose self-directed use has gone undocumented in the peer-reviewed literature: U.S. combat veterans with PTSD.
The Microdosing Vets study is led by Patrick Nienaber, principal investigator, under the direction of dissertation chair Jenny Wade, PhD. The dissertation committee includes Stanley Krippner, PhD (internal) and Grace Blest-Hopley, PhD (external). James Fadiman, PhD, originator of the modern microdosing protocol, serves as informal advisor.
The research team page includes selected publications and external profiles for each member.
Take the five-minute eligibility screening. If you qualify, you'll hear back from Patrick directly.
Begin the screening →Each veteran nominates someone close to them as a Friendly Observer. If you have a vet in your life who might be a fit, this page explains the FO role and gives you three ways to share the study with them.
Learn the Friendly Observer role →The media kit includes graphics, captions, the press release, and a researcher bio. Direct inquiries to research@foundationlabs.us.
View the media kit →Conducted through the California Institute of Integral Studies. Supported by the Pat Tillman Foundation Scholarship (2023) and the Robert Joseph & Wilhelmina Ann Kranzke Research Scholarship.
Patrick's own path to this point has been supported by the U.S. Department of Veterans Affairs and Disabled American Veterans — without their support, none of this would have been possible. The research itself is made possible by the U.S. combat veterans who talk about this material on the record, and by the partners, family members, and friends who agree to serve as Friendly Observers alongside them.
Five-minute eligibility screening. You'll talk with a fellow combat veteran researcher.
Take the 5-Min Screening →